Positive topline results in a Phase II clinical trial of a licensee’s alopecia treatment using the ProSilic ® variant of SiSaf’s Bio-Courier ® delivery technology Formulation of the small molecule ...
An undisclosed licensee of SiSaf’s Bio-Courier technology has completed patient enrolment for its clinical trial of an alopecia treatment using SiSaf’s hybrid silicon lipid nanoparticle delivery ...
LONDON--(BUSINESS WIRE)--Croda International Plc (‘Croda’) and SiSaf Ltd (‘SiSaf’) have today announced an exciting new strategic partnership. Croda, the name behind high performance ingredients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results